1. "Maria Arcila"
  2. "Marc Ladanyi"
  3. "Marc Rosenblum"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (4)
  3. Research Letter (1)
Groups
  1. GSK Faculty (13)
  2. Human Oncology and Pathogenesis Program (13)
  3. Tow Center for Developmental Oncology (TCDO) (13)
  4. Sloan Kettering Institute Postdocs (6)
  5. Center for Pancreatic Cancer Research (4)
  6. Radiology, Department of (4)

More Groups

People
  1. Marc Ladanyi (13)
  2. Marc Rosenblum (13)
  3. Maria Arcila (13)
  4. Ingo Mellinghoff (8)
  5. Tejus Bale (8)
  6. Ahmet Zehir (7)

More People

Years
  1. 2023 (3)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (1)
  6. 2015 (4)
Publications
  1. Journal of Molecular Diagnostics (3)
  2. Journal of Neuropathology and Experimental Neurology (2)
  3. Laboratory Investigation (2)
  4. Acta Neuropathologica (1)
  5. Acta Neuropathologica Communications (1)
  6. Genes Chromosomes and Cancer (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (3)
  2. American Society of Clinical Oncology (2)
  3. Nature Publishing Group (2)
  4. Oxford University Press (2)
  5. BioMed Central Ltd. (1)
  6. Nature Research (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
    Research Letter

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Reiner, A. S.; Cimera, R.; Nandakumar, S.; Price, A.; Vanderbilt, C.; Fahy, T.; Young, R. J.; more...
    Acta Neuropathologica (2023)

    Fulltext@MSK | Save
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Clinical validation of a DNA methylation-based central nervous system tumor classifier: The Memorial Sloan Kettering experience
    Meeting Abstract

    Benhamida, J.; Bale, T.; Nafa, K.; Rosenblum, M.; Villafania, L.; Sadowska, J.; Ziegler, J.; Lachhander, S.; Zehir, A.; Arcila, M.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling
    Journal Article

    Bale, T. A.; Yang, S. R.; Solomon, J. P.; Nafa, K.; Middha, S.; Casanova, J.; Sadowska, J.; Skakodub, A.; Ahmad, H.; Yu, H. A.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
    Journal Article

    Mata, D. A.; Benhamida, J. K.; Lin, A. L.; Vanderbilt, C. M.; Yang, S. R.; Villafania, L. B.; Ferguson, D. C.; Jonsson, P.; Miller, A. M.; Tabar, V.; more...
    Acta Neuropathologica Communications (2020)

    Fulltext@MSK | Save
  • Associations between FGFR3 activating fusions, molecular genetic profiles, and epigenetic methylation signatures in glioblastomas
    Meeting Abstract

    Mata, D.; Benhamida, J.; Lin, A.; Jonsson, P.; Villafania, L.; Ferguson, D.; Benayed, R.; Bowman, A.; Miller, A.; Mellinghoff, I.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Clinical sequencing of cell-free DNA from CSF is superior to cell pellet genomic DNA
    Meeting Abstract

    Bale, T.; Solomon, J.; Nafa, K.; Middha, S.; Casanova, J.; Sadowska, J.; Skakodub, A.; Rosenblum, M.; Pentsova, E.; Miller, A.; more...
    Journal of Neuropathology and Experimental Neurology (2019)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save